U.S. FDA Approves TG Therapeutics’ Multiple Sclerosis Drug; Shares Surge
TG Therapeutics Inc stated on Wednesday that the U.S. fitness regulator had accredited its monoclonal antibody for treating sufferers with relapsing varieties of more than...